Multislice CT angiography should be the preferred choice over MR angiography or duplex ultrasound for initial evaluation of patients with suspected peripheral arterial disease.
Multislice CT angiography should be the preferred choice over MR angiography or duplex ultrasound for initial evaluation of patients with suspected peripheral arterial disease.
Dr. Rody Ouwendijk of the Erasmus University Medical Center in Rotterdam, the Netherlands, drew this conclusion from a four-hospital study involving 514 patients with arteriosclerosis in their lower limbs. Patients were randomly selected to receive CTA, MRA, and duplex ultrasound. The clinical and financial effects of the studies were evaluated six months later.
Results, published in the May American Journal of Roentgenology (2008:190:1349-1357), indicate that CTA and MRA were relatively equivalent to one another clinically and demonstrably better than duplex ultrasound.
At an average cost of €104 per procedure, duplex ultrasound was less expensive than CTA (€163) or MRA (€472).
The advantage shifted to CTA and MRA, however, when vascular radiologists and surgeons surveyed for the study had significantly more therapeutic confidence in those two modalities than duplex ultrasound. Within 60 days after initial testing, more additional vascular imaging tests were performed on the patients who had received duplex ultrasound first than on patients who were evaluated with CTA or MRA.
No significant differences were seen in the number of additional tests for patients in the CTA and MRA groups or for quality-of-life measures for patients evaluated with any of the three modalities.
The potential for saving money with CTA led Ouwendijk and colleagues to recommend that modality, considering that its clinical performance was about the same as MRA and demonstrably better than duplex ultrasound.
The main disadvantages of CTA, established in the published medical literature, are patient exposure to ionizing radiation, the use of potentially nephrotoxic iodinated contrast media, and the confounding effects of vessel wall calcifications on image intrepretation.
For more information from the Diagnostic Imaging archives:
MR angiography illustrates runoff in diabetic patients
CTA revolutionizes treatment of peripheral vascular disease
Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa
March 6th 2025In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).
Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?
March 4th 2025In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.
Emerging AI Software for Prostate MRI Offers 95 Percent Sensitivity for csPCa
February 28th 2025In a multicenter study involving over 1,000 patients, a deep learning software offered comparable sensitivity and specificity for Gleason grade group > 2 tumors in comparison to radiologist interpretation.